SCHEMBL6458060

SCHEMBL6458060

Oc1ccc(C(O)CNCc2ccccc2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.64
SLC16A3 O15427 1/20 0.58
KDM4E B2RXH2 3/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
MEN1 O00255 1/20 0.57
KMT2A Q03164 1/20 0.57
ADRB3 P13945 1/20 0.54
PLA2G1B P04054 1/20 0.54
POLB P06746 1/20 0.54
ATG4B Q9Y4P1 1/20 0.54
ALDH1A1 P00352 1/20 0.53
HTR1A P08908 1/20 0.53
THPO P40225 1/20 0.53
BLM P54132 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
NMUR2 Q9GZQ4 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
CYP2C9 P11712 1/20 0.53
HIF1A Q16665 1/20 0.53
TAAR1 Q96RJ0 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6463866 0.98 LMNA (0.67) LMNASLC16A3KDM4EL3MBTL1MEN1
SCHEMBL13960329 0.95 LMNA (0.72) LMNASLC16A3KDM4EL3MBTL1MEN1
SCHEMBL10877713 0.91 LMNA (0.60) LMNASLC16A3KDM4EL3MBTL1MEN1
SCHEMBL7278068 0.89 LMNA (0.77) LMNASLC16A3KDM4EL3MBTL1MEN1
SCHEMBL2289990 0.89 LMNA (0.77) LMNASLC16A3KDM4EL3MBTL1MEN1
SCHEMBL1849603 0.89 LMNA (0.77) LMNASLC16A3KDM4EL3MBTL1MEN1
SCHEMBL10133058 0.86 LMNA (0.84) LMNASLC16A3KDM4EL3MBTL1MEN1
SCHEMBL7606905 0.86 BCHE (0.53) LMNASLC16A3MEN1KMT2ATDP1
SCHEMBL2295189 0.85 LMNA (0.62) LMNASLC16A3KDM4EL3MBTL1MEN1
SCHEMBL14646432 0.85 LMNA (0.68) LMNASLC16A3KDM4EL3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005108381-A1 SYNTHESIS AND USES OF SYNEPHRINE DERIVATIVES SYNTECH (SSPF) INTERNATIONAL INC. (US) 2005-11-17 WO disclosed
US-20050250944-A1 Synthesis and uses of synephrine derivatives SYNTECH (SSPF) INTERNATIONAL INC. 2005-11-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050250944-A1 Synthesis and uses of synephrine derivatives ADRB3, ADRB2, ADRB1 LMNA 642/4885SLC16A3 3620/4885KDM4E 2613/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.